The association between anthropometric indicators of obesity and cardiac reverse remodelling with empagliflozin in patients with type 2 diabetes and coronary artery disease
Abstract
Division of Cardiac Surgery, St Michael's Hospital of Unity Health Toronto, Toronto, Ontario, Canada Li Ka Shing Knowledge Institute of St Michael's Hospital, Toronto, Ontario, Canada Faculty of Medicine, University of British Columbia, Vancouver, British Columbia, Canada Division of Cardiothoracic Surgery, Emory University School of Medicine, Atlanta, Georgia, USA Wake Forest University, Winston-Salem, North Carolina, United States Michael G. DeGroote School of Medicine, McMaster University, Hamilton, Ontario, Canada School of Medicine, Royal College of Surgeons in Ireland, Dublin, Ireland Division of Cardiology, St Michael's Hospital of Unity Health Toronto, Toronto, Ontario, Canada Department of Medicine, University of Toronto, Toronto, Ontario, Canada Department of Physiology, University of Toronto, Toronto, Ontario, Canada Division of Endocrinology and Metabolism, St Michael's Hospital of Unity Health Toronto, Toronto, Ontario, Canada Department of Anaesthesia, St Michael's Hospital of Unity Health Toronto, Toronto, Ontario, Canada Department of Anaesthesiology and Pain Medicine, University of Toronto, Toronto, Ontario, Canada Department of Pharmacology and Toxicology, University of Toronto, Toronto, Ontario, Canada Department of Surgery, University of Toronto, Toronto, Ontario, Canada
Read the paper
Related studies
- Strategy for Mitigating DKA Risk in Patients with Type 1 Diabetes on Adjunctive Treatment with SGLT Inhibitors: A STICH Protocol
- Glucoraphanin: a broccoli sprout extract that ameliorates obesity-induced inflammation and insulin resistance
- SGLT2 Inhibitors in Heart Failure: Targeted Metabolomics and Energetic Metabolism
- Mechanisms of blood pressure reduction with sodium-glucose co-transporter 2 (SGLT2) inhibitors
- Sodium-glucose cotransporter inhibitors: beyond glycaemic control
- Decoding the effects of SGLT2 inhibitors on cardiac arrhythmias in heart failure
Go deeper in Evidence Hub
Evidence Hub adds a study data sheet (design, sample size, evidence level, key numbers), an AI summary and a chat grounded in the paper's text.